MKMohamed Khaled

Mohamed Khaled

*This is an algorithmically generated author record based on publicly available information.

Mohamed Khaled has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improving Zero-Shot Text Matching for Financial Auditing with Large Language Models

    by Lars Hillebrand, Armin Berger, Tobias Deußer, Tim Dilmaghani, Mohamed Khaled, Bernd Kliem, Rüdiger Loitz, Maren Pielka, David Leonhard, Christian Bauckhage, et al.

    Auditing financial documents is a very tedious and time-consuming process. As of today, it can already be simplified by employing AI-based solutions to recommend relevant text passages from a report for each legal requirement of rigorous accounting standards. However, these methods need to be fine-tuned regularly, and they require abundant annotated data, which is often lacking in industrial environments. Hence, we present ZeroShotALI, a novel recommender system that leverages a state-of-the-art large language model (LLM) in conjunction with a domain-specifically optimized transformer-based text-matching solution. We find that a two-step approach of first retrieving a number of best matching document sections per legal requirement with a custom BERT-based model and second filtering these selections using an LLM yields significant performance improvements over existing approaches.


  • Open Access

    Combination of Minoxidil 5% with Carboxytherapy versus Minoxidil 5% Alone in Treatment of Female Pattern Hair Loss

    by Fatma Alzahraa, Rabea Khedr, M. Ben Khaled, Galal Selim, Hanan Fathy, Alzahraa Fatma

    Background: Androgenic alopecia (AGA) is a genetically programmed condition brought on by a woman's disproportionate sensitivity to androgens. The frontal hairline is often spared whereas the crown and top of the head experience diffuse hair loss, which is frequently identified by a broader centre part. For women with AGA, topical minoxidil is a popular and successful therapy for hair loss. By reducing the telogen (resting) phase of hair follicles and activating the anagen (growth) phase, minoxidil encourages hair growth. Carboxytherapy is a noninvasive method that has been shown to affect hair development in a number of ways. Objective: To study the efficacy of combination of both minoxidil 5 % with carboxytherapy versus minoxidil 5 % alone in treatment of female pattern hair loss. Patients and methods: This study included 40 female patients with AGA, who were randomized into two groups (group A and B); Group A included patients who used minoxidil 5% once daily with carboxytherapy session every 3 weeks for 6 months and Group B who used topical minoxidil 5% only once daily for 6 months. Results: There was a statistically significant increase in hair diameter during treatment in group A compared to group B (at 3 months and 6 months) (p=0,012, 0.001 respectively). There was a statistically significant increase in hair density during treatment in group A compared to group B (at 3 months and 6 months) (p = 0.004, < 0.001 respectively). There was a statistically significant increase in hair count during treatment in group A compared to group B (at 3 months and 6 months) (P=0.048, 0.002 respectively). Higher satisfaction was recorded in group A compared to group B with a statistically significant difference (P=0.049). Conclusion: In the context of female pattern hair loss, carboxytherapy seems to be a promising therapeutic modality and it could be used as a helpful adjuvant therapy of AGA in association with minoxidil. In addition, it is recommended for maintenance of the results with minimal side effects.